Imvax Email Formats

Biotechnology Research • Philadelphia, Pennsylvania, United States • 21-50 Employees

Imvax Email Formats

Imvax uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@imvax.com), used 66.7% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@imvax.com	66.7%
{first name}.{last name}	john.doe@imvax.com	18.5%
{first initial}	j@imvax.com	7.4%
{last name}.{last name}	doe.doe@imvax.com	7.4%

Key Contacts at Imvax

Terry Campbell

Director Of Microbiology And Qc Development

Charles D. Littleton

Facility Management Lead Director

Company overview

Headquarters	601 Walnut St, Philadelphia, Pennsylvania 19106, US
Phone number	+12679004110
Website	imvax.com
NAICS	541714
SIC	283
Keywords	Biotechnology, Research, Clinical Trials, Biopharmaceuticals, Immunotherapy, Autologous Vaccines, Glioblastoma Multiforme
Founded	2015
Employees	21-50
Socials

About Imvax

Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies. Imvax’s combination therapy uniquely captures the complete antigenic signature of a patient’s own tumor and converts it into a highly stimulatory ‘training program’ for the patient’s immune system. The comprehensive nature of this training is intended to result in both innate and adaptive immune stimulation to optimize long-term anti-tumor effects. The company’s lead program is in glioblastoma multiforme (GBM), an extremely aggressive form of brain cancer, with additional programs in other types of solid tumors.